Home-Based Extended Low-Dose Oral Misoprostol in Management of First-Trimester Pregnancy Loss in Low-Resource Communities: A Randomized Trial
- 51 Downloads
To investigate the efficacy, safety and tolerability of a home-based extended low-dose oral misoprostol for management of first-trimester pregnancy loss.
Materials and Methods
A randomized trial that was conducted in the Woman’s Health University Hospital and El-eman Maternity Hospital, Assiut, Egypt. One hundred and sixty patients were included. They were randomly assigned to receive four tablets of 200 μg misoprostol vaginally (max. 800 μg-hospital group) or 12 tablets orally, one every 3 h, over 2 consecutive days (max. 2400 μg-extended low-dose home group). For failed first dose, another similar second dose was given. Primary outcome measure was the percentage of patients with ‘medically completed miscarriages’ in each group (including complete miscarriages + incomplete miscarriages with successful post-miscarriage misoprostol).
The total number of patients with ‘medically completed miscarriages’ in home group was 65/79 (82.3%), which was comparable to the hospital group (52/71 or 73.2%) (P = 0.182). However, the majority of patients in home group had significantly successful miscarriages after a single course of low-dose oral misoprostol, experienced much less heavy bleeding attacks and had less systemic side effects.
In low-resource communities, the home-based extended low-dose oral misoprostol protocol proved high efficacy, safety and tolerability in management of first-trimester pregnancy loss.
KeywordsOral misoprostol Low dose First trimester Pregnancy loss
Compliance with Ethical Standards
Conflict of interest
All authors declare that they have no conflict of interest.
Obtained approval of the ethical review committees of the department of Obstetrics and Gynecology and Assiut College of Medicine.
Informed consent was obtained.
- 1.National Institute for Health and Care Excellence (NICE). Ectopic pregnancy and miscarriage: diagnosis and initial management in early pregnancy of ectopic pregnancy and miscarriage (CG154). London: NICE. 2012. https://www.nice.org.uk/guidance/CG154/chapter/1-Recommendations#management-of-miscarriage. Accessed 11 Nov 2018.
- 4.FIGO Guideline: Misoprostol Recommended Dosages 2012. https://www.figo.org/sites/default/files/uploads/project-publications/Miso/Misoprostol_Recommended%20Dosages%202012.pdf. Accessed 17 Jan 2017.
- 6.Saraswat L, Ashok PW, Mathur M. Medical management of miscarriage. Obstet Gynaecol. 2014;16:79–85.Google Scholar
- 8.Metwaly AB, Abbas AM, Al-Sakkaf M. The use of single dose of oral misoprostol (600 µg) at home in management of first trimester miscarriages in El-Mukala, Yemen. Int J Reprod Contracept Obstet Gynecol. 2017;5(5):1360–3.Google Scholar
- 10.Gupta S, Sharma R, Rizvi S. Study on use of oral misoprostol for medical evacuation of missed abortion. Int J Sci Res. 2017;6(10):604–5.Google Scholar
- 14.Arain RF, Arain RF. Use of misoprostol in missed abortion—a double edged sword in anemia prevailing countries. IOSR J Dent Med Sci (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 16, Issue 3 Ver. VI; 2017. p. 100–103.Google Scholar